CorriXR Therapeutics Appoints Jill Castilla to Board of Directors

Share This Post

Key Highlights

  • Jill Castilla, President & CEO of Citizens Bank of Edmond, joins CorriXR’s Board of Directors.
  • Visionary leader in finance and banking with national recognition.
  • Former U.S. Army member and prominent contributor to economic recovery efforts during COVID-19.
  • Recipient of prestigious awards including American Banker’s 25 Most Powerful Women in Banking.

Source: Business Wire

Notable Quote

  • “We are very pleased to welcome Jill to our Board and believe she will be an invaluable asset with her vision and strong leadership skills. We trust that Jill’s proven record of success and extensive experience will help drive strategic growth, expand opportunities, and deliver value to the company.” — Deborah Moorad, Chief Executive Officer at CorriXR

SoHC's Take

The addition of Jill Castilla to CorriXR’s Board of Directors signals a strategic move to enhance the company’s financial and operational leadership. Castilla’s deep experience in both the public and private sectors, including her work with the Federal Reserve and as a driving force behind economic recovery during the pandemic, positions CorriXR to navigate complex financial landscapes while pushing forward with innovative gene therapies in oncology. Her track record of success in banking and civic leadership offers immense value as CorriXR aims to overcome drug resistance in cancer treatment.

Heading

Key Highlights Shore Capital Partners launches Agentis Longevity to lead the longevity healthcare sector. Jimmy St Louis named CEO, bringing expertise from Regenerative Medicine ...
/
Key Highlights Nymbl Systems announces strategic partnership with Frontier Growth to accelerate growth and innovation. Frontier Growth brings 25+ years of growth equity expertise to ...
/
Key Highlights Launch of fingertip blood collection technology using BD’s MiniDraw™ and Babson’s BetterWay for U.S. health systems. Revolutionizes access with fewer ...
/
Key Highlights Anatomy Financial raises $19M in Series A funding, led by Canapi Ventures. Neil Underwood (Canapi) and Nicole Quinn ...
/
Key Highlights Wendy Barnes to assume role as GoodRx CEO on January 1, 2025. Brings 30+ years of leadership in pharmacy and healthcare benefit industries. Former CEO of RxBenefits and President of Express ...
/
Key Highlights Mike Butler, former Providence president, joins Linus Health's board of directors. Butler brings decades of healthcare leadership and ...
/

More To Explore

Total
0
Share